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TO THE EDITOR
Activation of the extracellular signal-
regulated kinase (ERK) pathway has
an undisputed role in melanoma devel-
opment. The majority of human mela-
nomas harbor activating mutations in
N-RAS (4–50% of primary melanoma)
or B-RAF (20–80% of primary melano-
ma) (reviewed by Platz et al., 2008).
These mutations are mutually exclu-
sive, appear early, and are detectable in
up to 80% of benign nevi (reviewed by
Reifenberger et al., 2002; Thomas,
2006). Thus, aberrant ERK signaling is
not sufficient to induce melanoma but
triggers an initial cycle of melanocyte
proliferation that is subsequently lim-
ited by the onset of cellular senescence
(Michaloglou et al., 2005).
There is also accumulating evidence
that oncogenic activity differences may
exist between activated N-RAS and
B-RAF, as demonstrated by the unique
transcriptional signatures resulting from
mutations in these oncogenes (Pavey
et al., 2004) and the distinct histology
of B-RAF versus N-RAS mutation-posi-
tive melanomas (Viros et al., 2008). To
evaluate the oncogenic activity of
activated N-RAS and B-RAF, the
melanoma-associated N-RASQ61K or
B-RAFV600E mutants were transduced
into two primary human melanocytes
(HEM1455 and HEM1259). As ex-
pected, the accumulation of wild-type
B-RAF or the coexpressed copepod
green fluorescent protein (copGFP) did
not induce ERK activation, whereas
N-RASQ61K and B-RAFV600E induced
increased levels of phosphorylated
ERK (Figure 1a). Importantly, the
level of ERK phosphorylation in onco-
gene-transduced melanocytes was
comparable with endogenous ERK
phosphorylation in melanoma cells
with activated mitogen-activated pro-
tein kinase signaling (Supplementary
Figure S1 online).
The accumulation of B-RAFV600E,
but not wild-type B-RAF, oncogenic
N-RAS, or copepod green fluorescent
protein, also induced dramatic mor-
phological changes; melanocytes
displayed fewer dendrites, appeared
rounded, and the majority detached
from the culture flask (Figure 1b and c).
Importantly, V600E-induced loss of
substrate adhesion continued for the
length of our experiments, up to 7 days
post-transduction (data not shown).
The resulting suspension melanocytes
appeared rounded, viable, formed
loose clusters, and continued to
express B-RAFV600E and activated ERK
(Figure 1a and b). Trypan blue exclu-
sion assays demonstrated that approxi-
mately 90% of B-RAFV600E expressing
suspension melanocytes remained vi-
able, whereas a substantial proportion
of the suspension melanocytes expres-
sing wild-type B-RAF, N-RASQ61K, or
copepod green fluorescent protein
(suspension cells accounted for only
2–10% of these populations) were not
viable (Figure 1c).
To determine whether the impact of
oncogenic B-RAF on cell adhesion was
specific to melanocytes, we repeated
the transduction experiments in two
primary human dermal fibroblasts
(HDF1314 and WS-1). Oncogenic B-RAF
and N-RAS activated the ERK path-
way. Occasionally, wild-type B-RAF
also induced ERK phosphorylation in
these cells (Figure 1a), and although
this has been observed previously
(Gray-Schopfer et al., 2006) it was not
a consistent finding in our studies.
Expression of oncogenic B-RAF also
altered the morphology of fibroblasts
(Figure 1d), but these cells remained
adhered (Figure 1e). Moreover, the
small proportion of B-RAFV600E fibro-Abbreviation: ERK, extracellular signal-regulated kinase
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blasts in suspension (between 0.5 and
8%) showed low viability (Figure 1e).
These data confirm that cell rounding
and loss of substrate adhesion are
specific to oncogenic B-RAF in mela-
nocytes.
When anchorage-dependent cells
detach from the extracellular matrix,
they usually undergo apoptotic cell
death known as anoikis, and acquired
resistance to anoikis is associated with
transformation and immortalization (re-
viewed by Gilmore, 2005). To examine
whether oncogenic B-RAFV600E pre-
vented anoikis in human melanocytes,
the proportion of cells undergoing
apoptosis was determined using annex-
in V and propidium iodide staining. The
loss of adhesion induced by B-RAFV600E
did not induce anoikis; 80–90% of
suspension melanocytes remained
viable (Figure 2a and b). In contrast,
the minor proportion of melanocytes
in suspension post-transduction with
copepod green fluorescent protein
or wild-type B-RAF underwent apop-
tosis (Figure 2a and b). Intriguingly,
although mutant N-RAS did not
induce a significant loss of adhesion
(see Figure 1c), a considerable propor-
tion of N-RASQ61K-positive suspension
melanocytes remained viable, suggest-
ing that anoikis prevention may involve
the common downstream ERK pathway
(Figure 2a and b). Indeed, N-RASQ61K
has been shown to prevent anoikis
efficiently by Bim repression in immor-
talized PIG1 melanocytes (Goldstein
et al., 2009).
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Figure 1. B-RAFV600E promotes loss of substrate adhesion in human melanocytes. (a) Melanocytes and fibroblasts were infected with the indicated lentivirus
constructs (Haferkamp et al., 2009). The levels of phosphorylated extracellular signal-regulated kinase (p-ERK) were compared 3 days post-infection in adhered
and suspension cells, suspension cells only (S), or adherent cells only (A). Adequate numbers of suspension cells could only be obtained from B-RAFV600E-
transduced melanocytes, and no N-RAS samples are included in the suspension-only blot. (b) Morphological changes induced in melanocytes transduced
for 3 days with the indicated constructs. A cluster of suspension melanocytes expressing B-RAFV600E is indicated with an arrow (bar¼100 mm). (c) Melanocytes
were transduced with the indicated constructs for 3 days and the percentage of viable and non-viable suspension cells was determined by trypan blue exclusion.
(d) Morphological changes in fibroblasts transduced with the indicated expression constructs (bar¼ 100mm). (e) Fibroblasts were transduced with the
indicated lentiviral constructs for 3 days and the percentage of viable and non-viable suspension cells was determined.
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It is worth noting that protection
from anoikis has been associated with
cell cycle arrest (Collins et al., 2005)
and B-RAFV600E rapidly arrests melano-
cytes (Supplementary Figure S2a
online). It is unlikely that arrest is the
only requirement for protection from
anoikis, however, as N-RASQ61K also
promotes arrest in melanocytes, and
we have not detected a significant
increase in suspension melanocytes
up to 15 days post-N-RASQ61K trans-
duction (Haferkamp et al., 2009).
Furthermore, the B-RAFV600E-positve
NM182 melanoma cells have 10–15%
of cells in suspension and these cells
show no signs of cell cycle arrest and
depend on B-RAFV600E signaling for
their survival (Supplementary Figure S2b,
S2c online). These data suggest that
B-RAFV600E can protect melanocytes
from anoikis independently of cell
cycle inhibition.
To ensure that anoikis was not simply
delayed in response to B-RAFV600E expres-
sion, the suspension melanocytes were
maintained for up to 3 weeks post-
transduction. These cells remained
rounded, in loose clusters and most
were viable (Figure 2c). These find-
ings demonstrate that oncogenic B-RAF
is distinct from oncogenic N-RAS in
inducing cell detachment and prevent-
ing anoikis of human melanocytes. This
is supported by recent reports that
confirmed B-RAFV600E inhibited anoikis
in melanoma cell lines by repressing
the proapoptotic Bim and Bad proteins
and inducing the prosurvival Mcl-1
protein (Boisvert-Adamo and Aplin,
2006; Boisvert-Adamo et al., 2009).
The impact of B-RAFV600E on mela-
nocyte adhesion and survival could
conceivably increase cell motility and
may account for the unique histopatho-
logical characteristics of B-RAFV600E
melanomas, including upward migra-
tion of cells into the epidermal layer
and intraepidermal ‘‘nest’’ formation
(Viros et al., 2008). Our data are also
in line with evidence demonstrating
that oncogenic B-RAF is more potent
than N-RAS in supporting anchorage
independency. In particular, melanoma
cells derived from a single tumor
carrying cells with the B-RAFV600E or
N-RASQ61R mutation formed significantly
more soft agar colonies and exhibited
greater viability in suspension if they were
B-RAFV600E positive (Sensi et al., 2006).
Taken together, these data highlight that
activated B-RAF may not only signal
through the mitogen-activated protein
kinase cascade but may also signal with
different intensity or through alterative
pathways that regulate the adhesion and
survival of melanocytes. These B-RAF-
specific pathways deserve careful ex-
ploration as they may confer distinct
proliferative and survival characteristics
on B-RAFV600E melanomas.
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Figure 2. B-RAFV600E prevents anoikis. (a) Adhered and suspension melanocytes transduced with the indicated lentiviral constructs for 3 days were analyzed
for the proportion of apoptotic cells using annexin V staining by flow cytometry analysis. (b) The same cell populations were tested for their proportion of
apoptotic, sub-G1 cells with propidium iodide staining and flow cytometry analysis. (c) B-RAFV600E-transduced melanocytes were maintained in suspension
culture for 3 weeks and tested for the proportion of apoptotic cells with annexin V staining by flow cytometry analysis.
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TO THE EDITOR
Laminin-332 is a large extracellular
basement membrane zone protein that
is critical for dermal–epidermal cohe-
sion. The laminin-332 heterotrimer (a3/
b3/g2) is believed to link keratinocytes
with the basement membrane zone by
simultaneously binding epidermal in-
tegrin receptors via the C-terminal
globular domain of its a3 chain, and
type VII collagen through domains on
the short arm of its b3 chain (Chen
et al., 1997; Rousselle et al., 1997).
Antibody-induced inhibition of lami-
nin-332’s integrin-binding domains
produces extensive skin blistering
(Rousselle et al., 1991; Kirtschig et al.,
1995); however, the in vivo signi-
ficance of the laminin b3 short arm in
dermal–epidermal cohesion has not
been tested directly.
To further study the laminin b3 short
arm in dermal–epidermal cohesion, we
produced two deletion mutants of the
laminin b3 cDNA. One (DVI) contained
a deletion of domain VI (LN) but left the
type VII collagen-binding domain intact.
The other contained a deletion of the
entire b3 short arm I comprising
domains VI and V-III (LN, LE, LF), which
includes the collagen-binding region
(DVI-III). Mutant and wild-type (WT) b3
chain cDNAs were retrovirally ex-
pressed in laminin b3 null junctional
epidermolysis bullosa (JEB Null) primary
keratinocytes (Waterman et al., 2007).
DVI, DVI-III, and WT keratinocytes
were cultured atop the devitalized
dermis as described (Ortiz-Urda et al.,
2003) and the resulting skin equivalents
were examined 3–4 weeks after grafting
to severe combined immunodeficiency
mice (Figure 1a). WT grafts showed no
clinical or microscopic blistering,
where as DVI and DVI-III grafts showed
significant subepidermal blistering and
erosions. Laminin-332 null grafts uni-
formly failed, with no evidence
of overlying human epidermis (not
shown).
Increased granulation tissue has long
been recognized as a characteristic
feature of patients with lethal and
non-lethal JEB (Marinkovich and Bauer,
2008). Interestingly, DVI and DVI-III
grafts also showed prominent granula-
tion tissue (Figure 1b), confirming an
association of granulation tissue with
laminin-332 defects. Non-blistered
areas of mutant grafts showed a linear
deposition of laminin-332 and type VII
collagen at the dermal–epidermal junc-
tion, similar to WT cells (Figure 1c),
suggesting that blistering/granulation
tissues in mutant skin equivalents wer-
enot due to reduced laminin-332 or
type VII collagen deposition at the
dermal–epidermal junction. As these
studies were performed in immunodefi-
cient mice, it is likely that laminin-332
defects promoted the development of
granulation tissue without the involve-
ment of the memory immune system.
Scanning and transmission electron
microscopic analysis (Figure 2a) of JEB
Null keratinocytes before grafting
showed marked rounding and poor
association with the culture surface,
compared with the flat and well-
attached WT keratinocytes. Both DVI
and DVI-III cells showed degrees of
flattening and culture substrate apposi-
tion intermediate between JEB Null and
WT cells.
Mutant DVI and DVI-III skin analy-
zed by transmission electron microscopy
4 weeks after grafting (Figure 2b)
showed rudimentary hemidesmosomes
(HDs) compared with WT grafts. An-
choring fibrils in DVI grafts were
hypoplastic compared with WT control,
whereas little or no anchoring fibrils
were seen in DVI-III skin equivalents.
Separation of both DVI and DVI-III
grafts occurred in the lamina lucida,
with a continuous lamina densa (LD,
arrows) on the dermal side of the split.
DVI-III skin grafts were noted to
contain both HD defects associatedAbbreviations: HD, hemidesmosome; JEB Null, null junctional epidermolysis bullosa; WT, wild type
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